11. November 2009 00:32
Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug Administration. The product is available in bottles of 100 for immediate shipment to wholesalers and pharmacies nationwide.
[More]
22. October 2009 01:56
New analyses of the largest-ever clinical trial of patients with type 2 diabetes show that the combination of blood pressure lowering treatment and intensive glucose (blood sugar) control improved patients' vascular condition and resulted in a significant 18 percent reduction in the risk of death from all causes.
[More]
21. October 2009 06:39
New results from ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation), the largest clinical trial ever performed in patients with type 2 diabetes worldwide, provide important insights into the therapeutic strategy to adopt for efficient and safe blood glucose control aimed at the reduction of severe diabetes complications.
[More]
d8e49f6e-fc11-4cc6-9761-0d5e439f925d|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Atrial Fibrillation, Blood Pressure, Cardiovascular Disease, Cholesterol, Creatinine, Diabetes, Diabetes Mellitus, Diabetic Nephropathy, Hypoglycemia, Perindopril, Type 2 Diabetes
23. July 2009 21:28
A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine.
[More]
9c7d7d6f-3459-4dc8-afc4-0ac002400c7c|0|.0
Posted in: Medical Research News
Tags: ACE-Inhibitor, Alzheimer's Disease, Captropril, Cognitive Function, Dementia, Fosinopril, Hypertension (High Blood Pressure), Lisinopril, Perindopril, Ramipril, Trandolapril
12. May 2009 07:44
Sinobiopharma, Inc. has announced that it has received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market its formulation of Perindopril, an anti-hypertension drug.
[More]
11. March 2009 23:23
Results from a large, international, randomised, controlled trial have shown that there is a strong link between diabetics who have an abnormal heart rhythm (atrial fibrillation) and an increased risk of other heart-related problems and death.
[More]
ade83f09-39c8-4508-8ba9-6b52584f568c|0|.0
Posted in: Medical Research News
Tags: Atrial Fibrillation, Blood Pressure, Cardiology, Cardiovascular Disease, Cholesterol, Diabetes, Heart Attack (Myocardial Infarction), Heart Failure, Perindopril, Statin, Stroke, Type 2 Diabetes
1. April 2008 05:08
Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new study presented at the American College of Cardiology in Chicago and published simultaneously in the New England Journal of Medicine.
[More]
10. October 2007 20:28
According to scientists from Dundee University in Scotland, when seniors were given a drug commonly prescribed for heart conditions they were able to do more exercise.
[More]
9. October 2007 00:52
A decline in physical function with age is strongly associated with disability in later life.
[More]
8. October 2007 11:40
New research, published in the Journal of American Society of Nephrology by The George Institute for International Health in Sydney, has found that lowering blood pressure protects stroke victims with Chronic Kidney Disease from further strokes or heart attacks.
[More]
3. October 2007 02:50
Preliminary research suggests that use of the ACE inhibitor perindopril, along with a beta-blocker, may help reduce cardiac measures such as aortic stiffness and dilation that are associated with the cardiac complications of Marfan syndrome, according to an article in the October 3 issue of JAMA.
[More]
5. September 2007 08:15
The largest-ever study of treatments for type 2 diabetes has shown that a combination of two blood pressure lowering drugs reduced the risk of death, as well as the risks of heart and kidney disease.
[More]
5. September 2007 08:07
A small reduction in blood pressure produced a significant benefit in the largest study ever done on the treatment of patients with type 2 diabetes, presented on Sunday in Vienna at the European Society of Cardiology Congress, and published online in the Lancet the same day.
[More]
8344e2a2-437b-4bd6-a3af-dc31f4ee24cc|0|.0
Posted in: Drug Trial News
Tags: Ace Inhibitor, ACE-Inhibitor, Aspirin, Blood Pressure, Cardiology, Cardiovascular Disease, Coronary Artery Disease, Coronary Heart Disease, Diabetes, Diuretic Drug, Kidney Disease, Perindopril, Statin, Type 2 Diabetes
5. September 2007 04:25
A team of Australian researchers say a once-a-day pill to lower blood pressure should be given routinely to people with diabetes to prevent heart disease, strokes and other medical complications.
[More]
2. September 2007 21:23
The largest-ever study of treatments for diabetes has shown that a fixed combination of two blood pressure lowering drugs reduces the risk of death, as well as the risks of heart and kidney disease. Results from the ADVANCE (Action in Diabetes and Vascular Disease) Study were presented today at the European Society of Cardiology Congress 2007 in Vienna.
[More] 
Subscribe